Profile
Kerstin B.
Menander worked as Head-Medical Oncology at Avid Bioservices, Inc. and as Vice President-Clinical Development at Introgen Therapeutics, Inc. Prior to that, she was Vice President-International Operations at Cell Pathways, Inc. from 1997 to 2002.
She received her undergraduate and doctorate degrees from the University of Lund.
Former positions of Kerstin B. Menander
| Companies | Position | End |
|---|---|---|
Cell Pathways, Inc.
 Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Cell Pathways, Inc. develops and commercializes drugs for the prevention and treatment of cancer | Corporate Officer/Principal | 01/01/2002 |
| AVID BIOSERVICES, INC. | Corporate Officer/Principal | - |
| INTROGEN THERPUT | Chief Tech/Sci/R&D Officer | 19/08/2010 |
Training of Kerstin B. Menander
| University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVID BIOSERVICES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Introgen Therapeutics, Inc.
 Introgen Therapeutics, Inc. Medical SpecialtiesHealth Technology Introgen Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company develops molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. The company maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility. It was founded in June 1993 and is headquartered in Austin, TX. | Health Technology |
Cell Pathways, Inc.
Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Cell Pathways, Inc. develops and commercializes drugs for the prevention and treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Kerstin B. Menander
